Phentermine
(NCAIGTHBQTXTLR-UHFFFAOYSA-N)
Structure
- SMILES
- CC(Cc1ccccc1)(N)C.Cl
- Molecular Formula:
- C10H16ClN
- Molecular Weight:
- 185.694
- Log P:
- 3.4687
- Hydrogen Bond Acceptor:
- 1
- Hydrogen Bond Donor:
- 2
- TPSA:
- 26.02
- CAS Number(s):
- 1197-21-3
Synonym(s)
1.
Phentermine
2.
Adipex-P
3.
Duromine
4.
Ionamine
5.
Phentermine Hydrochloride
6.
Adipex P
7.
AdipexP
8.
Hydrochloride, Phentermine
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 91 | US FAERS | |
| 2 | Headache | FAERS: 11 | US FAERS | |
| 3 | Fatigue | FAERS: 10 | US FAERS | |
| 4 | Arthralgia | FAERS: 9 | US FAERS | |
| 5 | Asthenia | FAERS: 8 | US FAERS | |
| 6 | Feeling Cold | FAERS: 7 | US FAERS | |
| 7 | Myalgia | FAERS: 7 | US FAERS | |
| 8 | Eye pain | FAERS: 6 | US FAERS | |
| 9 | Joint stiffness | FAERS: 6 | US FAERS | |
| 10 | Joint swelling | FAERS: 6 | US FAERS | |
| 11 | Dizziness | FAERS: 5 | US FAERS | |
| 12 | Feeling abnormal | FAERS: 5 | US FAERS | |
| 13 | Myocardial Infarction | FAERS: 5 | US FAERS | |
| 14 | Nausea | FAERS: 5 | US FAERS | |
| 15 | Chest Pain | FAERS: 4 | US FAERS | |
| 16 | Pain | FAERS: 4 | US FAERS | |
| 17 | Paranoia | FAERS: 4 | US FAERS | |
| 18 | Drug ineffective for unapproved indication | FAERS: 3 | US FAERS | |
| 19 | Somnolence | FAERS: 3 | US FAERS | |
| 20 | Therapeutic response unexpected | FAERS: 3 | US FAERS | |
| 21 | Urticaria | FAERS: 3 | US FAERS | |
| 22 | Alanine Aminotransferase Increased | FAERS: 2 | US FAERS | |
| 23 | Alopecia | FAERS: 2 | US FAERS | |
| 24 | Amyloidosis | FAERS: 2 | US FAERS | |
| 25 | Anxiety | FAERS: 2 | US FAERS | |
| 26 | Cerebrovascular accident | FAERS: 2 | US FAERS | |
| 27 | Chest discomfort | FAERS: 2 | US FAERS | |
| 28 | Dehydration | FAERS: 2 | US FAERS | |
| 29 | Encephalomalacia | FAERS: 2 | US FAERS | |
| 30 | Food craving | FAERS: 2 | US FAERS | |
| 31 | Head discomfort | FAERS: 2 | US FAERS | |
| 32 | Hunger | FAERS: 2 | US FAERS | |
| 33 | Hypotension | FAERS: 2 | US FAERS | |
| 34 | Malaise | FAERS: 2 | US FAERS | |
| 35 | Nephrotic Syndrome | FAERS: 2 | US FAERS | |
| 36 | Pharmaceutical product complaint | FAERS: 2 | US FAERS | |
| 37 | Phospholipidosis | FAERS: 2 | US FAERS | |
| 38 | Posterior reversible encephalopathy syndrome | FAERS: 2 | US FAERS | |
| 39 | Postrenal failure | FAERS: 2 | US FAERS | |
| 40 | Product quality issue | FAERS: 2 | US FAERS | |
| 41 | Product substitution issue | FAERS: 2 | US FAERS | |
| 42 | Pruritus | FAERS: 2 | US FAERS | |
| 43 | Vomiting | FAERS: 2 | US FAERS | |
| 44 | Abdominal Pain | FAERS: 1 | US FAERS | |
| 45 | Acne | FAERS: 1 | US FAERS | |
| 46 | Agitation | FAERS: 1 | US FAERS | |
| 47 | Amnesia | FAERS: 1 | US FAERS | |
| 48 | Aspartate Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 49 | Blood glucose decreased | FAERS: 1 | US FAERS | |
| 50 | Blood pressure fluctuation | FAERS: 1 | US FAERS | |
| 51 | Cardiac Arrest | FAERS: 1 | US FAERS | |
| 52 | Cardiac Death | FAERS: 1 | US FAERS | |
| 53 | Cardiac ventricular disorder | FAERS: 1 | US FAERS | |
| 54 | Cerebral Infarction | FAERS: 1 | US FAERS | |
| 55 | Cholelithiasis | FAERS: 1 | US FAERS | |
| 56 | Constipation | FAERS: 1 | US FAERS | |
| 57 | Crying | FAERS: 1 | US FAERS | |
| 58 | Depressed mood | FAERS: 1 | US FAERS | |
| 59 | Drooling | FAERS: 1 | US FAERS | |
| 60 | Drug Dependence | FAERS: 1 | US FAERS | |
| 61 | Drug dose omission | FAERS: 1 | US FAERS | |
| 62 | Drug effect variable | FAERS: 1 | US FAERS | |
| 63 | Drug screen false positive | FAERS: 1 | US FAERS | |
| 64 | Drug screen negative | FAERS: 1 | US FAERS | |
| 65 | Drug withdrawal syndrome | FAERS: 1 | US FAERS | |
| 66 | Dysuria | FAERS: 1 | US FAERS | |
| 67 | Erectile dysfunction | FAERS: 1 | US FAERS | |
| 68 | Erythema | FAERS: 1 | US FAERS | |
| 69 | Feeling jittery | FAERS: 1 | US FAERS | |
| 70 | Gastrointestinal Pain | FAERS: 1 | US FAERS | |
| 71 | General physical health deterioration | FAERS: 1 | US FAERS | |
| 72 | Glossitis | FAERS: 1 | US FAERS | |
| 73 | Hyperphagia | FAERS: 1 | US FAERS | |
| 74 | Hyperreflexia | FAERS: 1 | US FAERS | |
| 75 | Hypersensitivity | FAERS: 1 | US FAERS | |
| 76 | Hypersomnia | FAERS: 1 | US FAERS | |
| 77 | Hyperventilation | FAERS: 1 | US FAERS | |
| 78 | Hypoperfusion | FAERS: 1 | US FAERS | |
| 79 | Impaired work ability | FAERS: 1 | US FAERS | |
| 80 | Incorrect drug administration duration | FAERS: 1 | US FAERS | |
| 81 | Intentional product misuse | FAERS: 1 | US FAERS | |
| 82 | Lethargy | FAERS: 1 | US FAERS | |
| 83 | Nervousness | FAERS: 1 | US FAERS | |
| 84 | Neuralgia | FAERS: 1 | US FAERS | |
| 85 | No adverse event | FAERS: 1 | US FAERS | |
| 86 | Oral pain | FAERS: 1 | US FAERS | |
| 87 | Palpitations | FAERS: 1 | US FAERS | |
| 88 | Panniculitis | FAERS: 1 | US FAERS | |
| 89 | Personality Change | FAERS: 1 | US FAERS | |
| 90 | Polydipsia | FAERS: 1 | US FAERS | |
| 91 | Product substitution | FAERS: 1 | US FAERS | |
| 92 | Pulmonary Hypertension | FAERS: 1 | US FAERS | |
| 93 | Pulmonary arterial hypertension | FAERS: 1 | US FAERS | |
| 94 | Restlessness | FAERS: 1 | US FAERS | |
| 95 | Rhabdomyolysis | FAERS: 1 | US FAERS | |
| 96 | Right Ventricular Hypertrophy | FAERS: 1 | US FAERS | |
| 97 | Stomatitis | FAERS: 1 | US FAERS | |
| 98 | Sudden Cardiac Death | FAERS: 1 | US FAERS | |
| 99 | Sudden death | FAERS: 1 | US FAERS | |
| 100 | Therapeutic product ineffective | FAERS: 1 | US FAERS | |
| 101 | Thirst | FAERS: 1 | US FAERS | |
| 102 | Tinnitus | FAERS: 1 | US FAERS | |
| 103 | Toxicity to various agents | FAERS: 1 | US FAERS | |
| 104 | Tremor | FAERS: 1 | US FAERS | |
| 105 | Unevaluable event | FAERS: 1 | US FAERS | |
| 106 | Urinary hesitation | FAERS: 1 | US FAERS | |
| 107 | Ventricular Fibrillation | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.